Probiotic Prophylaxis of Ventilator-associated Pneumonia
Top Cited Papers
- 15 October 2010
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 182 (8), 1058-1064
- https://doi.org/10.1164/rccm.200912-1853oc
Abstract
Rationale: Enteral administration of probiotics may modify the gastrointestinal environment in a manner that preferentially favors the growth of minimally virulent species. It is unknown whether probiotic modification of the upper aerodigestive flora can reduce nosocomial infections. Objectives: To determine whether oropharyngeal and gastric administration of Lactobacillus rhamnosus GG can reduce the incidence of ventilator-associated pneumonia (VAP). Methods: We performed a prospective, randomized, double-blind, placebo-controlled trial of 146 mechanically ventilated patients at high risk of developing VAP. Patients were randomly assigned to receive enteral probiotics (n = 68) or an inert inulin-based placebo (n = 70) twice a day in addition to routine care. Measurements and Main Results: Patients treated with Lactobacillus were significantly less likely to develop microbiologically confirmed VAP compared with patients treated with placebo (40.0 vs. 19.1%; P = 0.007). Although patients treated with probiotics had significantly less Clostridium difficile–associated diarrhea than patients treated with placebo (18.6 vs. 5.8%; P = 0.02), the duration of diarrhea per episode was not different between groups (13.2 ± 7.4 vs. 9.8 ± 4.9 d; P = 0.39). Patients treated with probiotics had fewer days of antibiotics prescribed for VAP (8.6 ± 10.3 vs. 5.6 ± 7.8 d; P = 0.05) and for C. difficile–associated diarrhea (2.1 ± 4.8 SD d vs. 0.5 ± 2.3 d; P = 0.02). No adverse events related to probiotic administration were identified. Conclusions: These pilot data suggest that L. rhamnosus GG is safe and efficacious in preventing VAP in a select, high-risk ICU population. Clinical trial registered with www.clinicaltrials.gov (NCT00613795).This publication has 43 references indexed in Scilit:
- Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Prevention and Management of Infections by ProbioticsJournal of Nutrition, 2010
- Probiotics in surgerySurgery, 2008
- Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot studyCritical Care, 2008
- Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patientsCritical Care, 2008
- Noninvasive mechanical ventilation during the weaning process: facilitative, curative, or preventive?Critical Care, 2008
- Supply of Pre- and Probiotics Reduces Bacterial Infection Rates After Liver Transplantation—A Randomized, Double-Blind TrialAmerican Journal of Transplantation, 2005
- Benefits of early enteral nutrition with glutamine and probiotics in brain injury patientsClinical Science, 2004
- A Novel Host-Parasite Lipid Cross-talkOnline Journal of Public Health Informatics, 2002
- Nosocomial infections in medical intensive care units in the United StatesCritical Care Medicine, 1999